CMPX — COMPASS THERAPEUTICS INC

Ownership history in Caption Management, LLC  ·  5 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in COMPASS THERAPEUTICS INC (CMPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.07% (2025 Q2)
Avg. % of fund
0.03%
First filed
2025 Q1
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 154,170 -845,830 -84.6% 0.00% $540K $3.50
2025 Q3 REDUCED 1,000,000 -1,493,500 -59.9% 0.03% $3.5M $3.50
2025 Q2 ADDED 2,493,500 +1,767,990 +243.7% 0.07% $6.5M $2.60
2025 Q2 ADDED 725,510 +164,310 +29.3% 0.02% $1.9M $2.60
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CMPX price (monthly, adj. close)

Other funds also holding CMPX

As of 2025 Q4 — sorted by position size

Birchview Capital, LP 3Y 7Y 5.01% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 4.45% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 3.99% CAXTON CORP 3Y 7Y 3.7% Vivo Capital, LLC 3Y 7Y 3.31% Monashee Investment Management LLC 3Y 7Y 3.03% Seven Fleet Capital Management LP 2.32% Palo Alto Investors LP 3Y 7Y 1.89% ORBIMED ADVISORS LLC 3Y 7Y 1.67% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.56%
← Back to Caption Management, LLC Holdings